EP. 3: Case 1: Neoadjuvant Therapy for Early-Stage HER2+ Breast CancerByTargeted OncologySeptember 11th 2020
EP. 4: Case 1: Choosing Therapy for Early Stage HER2+ Breast Cancer ByTargeted OncologySeptember 11th 2020
EP. 5: Case 1: Adjuvant Treatment for Residual Disease in Early Stage HER2+ Breast Cancer ByTargeted OncologySeptember 11th 2020
EP. 6: Case 1: Adjuvant Therapy After pCR in Early Stage HER2+ Breast Cancer ByTargeted OncologySeptember 11th 2020
EP. 8: Case 1: De-Escalation of Adjuvant Anti-HER2 Therapy for Breast Cancer ByTargeted OncologySeptember 11th 2020
EP. 9: Case 1: Subcutaneous Trastuzumab-Pertuzumab for HER2+ Breast Cancer ByTargeted OncologySeptember 11th 2020
EP. 13: Case 2: Impact of Brain Metastases in HER2+ Breast CancerByTargeted OncologySeptember 11th 2020
EP. 14: Case 2: Risk Factors for Brain Metastases in HER2+ Breast CancerByTargeted OncologySeptember 11th 2020
EP. 15: Case 2: Adverse Effects of Treatments for HER2+ Breast CancerByTargeted OncologySeptember 11th 2020
EP. 17: Case 2: Novel Agents in Late-Stage Clinical Trials for HER2+ MBCByTargeted OncologySeptember 11th 2020
EP. 19: Case 3: Distant Metastases in Triple-Positive Breast CancerByTargeted OncologySeptember 11th 2020
